• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于新冠病毒奥密克戎(B.1.1.529)变体的全面综述。

A comprehensive review on Covid-19 Omicron (B.1.1.529) variant.

作者信息

Manjunath R, Gaonkar Santosh L, Saleh Ebraheem Abdu Musad, Husain Kakul

机构信息

Department of Chemistry, Manipal Institute of Technology, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India.

Department of Chemistry, Prince Sattam Bin Abdulaziz University, College of Arts and Science, Wadi Al-Dawasir 11991, Saudi Arabia.

出版信息

Saudi J Biol Sci. 2022 Sep;29(9):103372. doi: 10.1016/j.sjbs.2022.103372. Epub 2022 Jul 15.

DOI:10.1016/j.sjbs.2022.103372
PMID:35855306
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9284530/
Abstract

The world has been combating different variants of SARS-COV-19 since its first outbreak in Wuhan city. SARS-COV-19 is caused by the coronavirus. The corona virus mutates and becomes more transmissible than earlier variants as the day passes. Till 24 November 2021, SARS-COV-19 has four variants Alpha, Beta, Gamma, and Delta, respectively. Among them, the delta variant caused severe havoc across the world. South Africa registered a new variant with the World Health Organization (WHO) on 24 November 2021, which is much more transmissible than previous variants. The WHO classified it as a variant of concern (VOC) on 26 November 2021 and called it the Greek letter Omicron (B.1.1.529), the fifteenth letter in the alphabet. Here a serious attempt was made to comprehend the omicron variant's origin, nomenclature, characteristics, mutations, the difference between delta and omicron variant, epidemiology, transmission, clinical features, impact on immunity, immune evasion, vaccines efficacy, etc.

摘要

自新冠病毒在武汉市首次爆发以来,全球一直在与新冠病毒的不同变种作斗争。新冠病毒是由冠状病毒引起的。随着时间的推移,冠状病毒会发生变异,并且变得比早期变种更具传染性。截至2021年11月24日,新冠病毒分别有阿尔法、贝塔、伽马和德尔塔四种变种。其中,德尔塔变种在全球造成了严重破坏。2021年11月24日,南非向世界卫生组织(WHO)报告了一种新变种,它比之前的变种更具传染性。2021年11月26日,世界卫生组织将其列为值得关注的变种(VOC),并将其命名为希腊字母奥密克戎(B.1.1.529),即字母表中的第十五个字母。在此,我们进行了认真的尝试,以了解奥密克戎变种的起源、命名、特征、突变、德尔塔变种与奥密克戎变种的区别、流行病学、传播、临床特征、对免疫的影响、免疫逃逸、疫苗效力等。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9309664/deacaa317c7e/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9309664/e111946ca544/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9309664/a55994764c94/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9309664/592113d1cd49/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9309664/44fd910358ca/gr4a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9309664/aa15ad2b526e/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9309664/b7c9f626de47/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9309664/be9cff219b44/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9309664/6beb5675e9d5/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9309664/deacaa317c7e/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9309664/e111946ca544/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9309664/a55994764c94/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9309664/592113d1cd49/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9309664/44fd910358ca/gr4a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9309664/aa15ad2b526e/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9309664/b7c9f626de47/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9309664/be9cff219b44/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9309664/6beb5675e9d5/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9309664/deacaa317c7e/gr9.jpg

相似文献

1
A comprehensive review on Covid-19 Omicron (B.1.1.529) variant.关于新冠病毒奥密克戎(B.1.1.529)变体的全面综述。
Saudi J Biol Sci. 2022 Sep;29(9):103372. doi: 10.1016/j.sjbs.2022.103372. Epub 2022 Jul 15.
2
Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant.接种 SARS-CoV-2 疫苗和感染 COVID-19 的人类血清对 SARS-CoV-2 奥密克戎变异株 RBD 的结合能力降低。
BMC Med. 2022 Mar 3;20(1):102. doi: 10.1186/s12916-022-02312-5.
3
Omicron variant in COVID-19 current pandemic: a reason for apprehension.奥密克戎变异株在当前 COVID-19 大流行中的出现:令人担忧的原因。
Horm Mol Biol Clin Investig. 2022 Sep 5;44(1):89-96. doi: 10.1515/hmbci-2022-0010. eCollection 2023 Mar 1.
4
A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.一种基于三聚体 RBD 的马赛克型 COVID-19 疫苗候选物可诱导针对奥密克戎和其他 SARS-CoV-2 变体的强大中和作用。
Elife. 2022 Aug 25;11:e78633. doi: 10.7554/eLife.78633.
5
A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.一种糖基化 RBD 蛋白诱导针对奥密克戎和其他变体的增强型中和抗体,提高对 SARS-CoV-2 感染的保护作用。
J Virol. 2022 Sep 14;96(17):e0011822. doi: 10.1128/jvi.00118-22. Epub 2022 Aug 16.
6
SARS-CoV-2 Omicron variant: Characteristics and prevention.严重急性呼吸综合征冠状病毒2型奥密克戎变异株:特征与预防
MedComm (2020). 2021 Dec 16;2(4):838-845. doi: 10.1002/mco2.110. eCollection 2021 Dec.
7
Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile.关于关注的 SARS-CoV-2 奥密克戎变异株及其特殊突变特征的最新信息。
Microbiol Spectr. 2022 Apr 27;10(2):e0273221. doi: 10.1128/spectrum.02732-21. Epub 2022 Mar 30.
8
A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern.一种靶向 RBD 和 S2 的双特异性抗体能有效中和 SARS-CoV-2 奥密克戎及其他关注变异株。
J Virol. 2022 Aug 24;96(16):e0077522. doi: 10.1128/jvi.00775-22. Epub 2022 Aug 2.
9
Sub-lineages of the SARS-CoV-2 Omicron variants: Characteristics and prevention.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎变种的亚谱系:特征与预防
MedComm (2020). 2022 Aug 16;3(3):e172. doi: 10.1002/mco2.172. eCollection 2022 Sep.
10
From Alpha to Omicron: How Different Variants of Concern of the SARS-Coronavirus-2 Impacted the World.从阿尔法到奥密克戎:严重急性呼吸综合征冠状病毒2的不同关注变异株如何影响世界
Biology (Basel). 2023 Sep 21;12(9):1267. doi: 10.3390/biology12091267.

引用本文的文献

1
Comparative analysis of neutrophil dynamics and disease in SARS-CoV-2 Delta and Omicron variants utilizing an feline model for COVID-19.利用猫科动物COVID-19模型对SARS-CoV-2 Delta和Omicron变体中的中性粒细胞动态和疾病进行比较分析。
Front Immunol. 2025 May 22;16:1547918. doi: 10.3389/fimmu.2025.1547918. eCollection 2025.
2
In-hospital mortality among children and adults hospitalized with COVID-19 in Africa across pre-delta, delta, and omicron SARS-CoV-2 waves.在非洲,儿童和成人因感染新冠病毒住院,在德尔塔毒株出现之前、德尔塔毒株时期以及奥密克戎毒株时期的住院死亡率。
Int J Infect Dis. 2025 Aug;157:107924. doi: 10.1016/j.ijid.2025.107924. Epub 2025 May 8.
3

本文引用的文献

1
Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes.奥密克戎或德尔塔变异株感染及重症的 COVID-19 疫苗有效性评估。
JAMA Netw Open. 2022 Sep 1;5(9):e2232760. doi: 10.1001/jamanetworkopen.2022.32760.
2
Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design.苏格兰关注的奥密克戎变异株的严重程度和疫苗加强针预防有症状疾病的效果(EAVE II):一项具有巢式病例对照研究设计的全国队列研究。
Lancet Infect Dis. 2022 Jul;22(7):959-966. doi: 10.1016/S1473-3099(22)00141-4. Epub 2022 Apr 22.
3
Genetic Diversity and Spatiotemporal Distribution of SARS-CoV-2 Variants in Guinea: A Meta-Analysis of Sequence Data (2020-2023).
几内亚新冠病毒变异株的遗传多样性与时空分布:序列数据的荟萃分析(2020 - 2023年)
Viruses. 2025 Jan 31;17(2):204. doi: 10.3390/v17020204.
4
Comparison of the Neutralization Power of Sotrovimab Against SARS-CoV-2 Variants: Development of a Rapid Computational Method.索托维单抗对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体的中和能力比较:一种快速计算方法的开发
JMIR Bioinform Biotechnol. 2024 Oct 10;5:e58018. doi: 10.2196/58018.
5
Individual risk factors associated with SARS-CoV-2 infection during Alpha variant in high-income countries: a systematic review and meta-analysis.与高收入国家阿尔法变异株期间 SARS-CoV-2 感染相关的个体风险因素:系统评价和荟萃分析。
Front Public Health. 2024 Jul 30;12:1367480. doi: 10.3389/fpubh.2024.1367480. eCollection 2024.
6
Impact of diabetes on COVID-19 and glucocorticoids on patients with COVID-19 and diabetes during the Omicron variant epidemic: a multicenter retrospective cohort study in South China.奥密克戎变异株流行期间糖尿病对 COVID-19 的影响及糖皮质激素对 COVID-19 合并糖尿病患者的影响:华南地区多中心回顾性队列研究。
BMC Infect Dis. 2024 Jul 18;24(1):706. doi: 10.1186/s12879-024-09287-z.
7
Detection of co-infection and recombination cases with Omicron and local Delta variants of SARS-CoV-2 in Vietnam.越南奥密克戎和本地德尔塔变异株 SARS-CoV-2 共感染和重组病例的检测。
Sci Rep. 2024 Jun 20;14(1):14225. doi: 10.1038/s41598-024-64898-5.
8
Mutational dynamics of SARS-CoV-2: Impact on future COVID-19 vaccine strategies.新型冠状病毒(SARS-CoV-2)的突变动态:对未来新冠疫苗策略的影响
Heliyon. 2024 Apr 25;10(9):e30208. doi: 10.1016/j.heliyon.2024.e30208. eCollection 2024 May 15.
9
Genetic features of SARS-CoV-2 Alpha, Delta, and Omicron variants and their association with the clinical severity of COVID-19 in Vietnam.新冠病毒阿尔法、德尔塔和奥密克戎变异株的基因特征及其与越南新冠肺炎临床严重程度的关联
IJID Reg. 2024 Mar 13;11:100348. doi: 10.1016/j.ijregi.2024.03.003. eCollection 2024 Jun.
10
Gastrointestinal microbiota and metabolites possibly contribute to distinct pathogenicity of SARS-CoV-2 proto or its variants in rhesus monkeys.胃肠道微生物群和代谢物可能导致 SARS-CoV-2 原型或其变体在恒河猴中具有不同的致病性。
Gut Microbes. 2024 Jan-Dec;16(1):2334970. doi: 10.1080/19490976.2024.2334970. Epub 2024 Apr 2.
Suboptimal antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients.
肾移植受者在接种第三剂mRNA疫苗后对新冠病毒奥密克戎变异株的抗体反应欠佳。
Kidney Int. 2022 Jun;101(6):1282-1286. doi: 10.1016/j.kint.2022.04.009. Epub 2022 Apr 13.
4
Estimation of Serial Interval and Reproduction Number to Quantify the Transmissibility of SARS-CoV-2 Omicron Variant in South Korea.估算 SARS-CoV-2 奥密克戎变异株在韩国的传播性:序列间隔和繁殖数的估计。
Viruses. 2022 Mar 4;14(3):533. doi: 10.3390/v14030533.
5
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant.Covid-19 疫苗对奥密克戎(B.1.1.529)变异株的有效性。
N Engl J Med. 2022 Apr 21;386(16):1532-1546. doi: 10.1056/NEJMoa2119451. Epub 2022 Mar 2.
6
Comparative Genomics and Characterization of SARS-CoV-2 P.1 (Gamma) Variant of Concern From Amazonas, Brazil.来自巴西亚马逊地区的新型冠状病毒2019(SARS-CoV-2)P.1(伽马)变异株的比较基因组学与特征分析
Front Med (Lausanne). 2022 Feb 15;9:806611. doi: 10.3389/fmed.2022.806611. eCollection 2022.
7
Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8 T-Cell Epitopes Identified in COVID-19 Convalescent Individuals.在 COVID-19 康复个体中鉴定的与 SARS-CoV-2 的奥密克戎变异株相关的突变和 CD8 T 细胞表位之间最小交叉。
mBio. 2022 Apr 26;13(2):e0361721. doi: 10.1128/mbio.03617-21. Epub 2022 Mar 1.
8
Main protease mutants of SARS-CoV-2 variants remain susceptible to nirmatrelvir.SARS-CoV-2 变体的主要蛋白酶突变体仍然对奈玛特韦敏感。
Bioorg Med Chem Lett. 2022 Apr 15;62:128629. doi: 10.1016/j.bmcl.2022.128629. Epub 2022 Feb 16.
9
An ultrapotent RBD-targeted biparatopic nanobody neutralizes broad SARS-CoV-2 variants.一种超高效靶向 RBD 的双价纳米抗体可中和广泛的 SARS-CoV-2 变体。
Signal Transduct Target Ther. 2022 Feb 9;7(1):44. doi: 10.1038/s41392-022-00912-4.
10
Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron.疫苗引发针对 SARS-CoV-2 奥密克戎的高度保守的细胞免疫。
Nature. 2022 Mar;603(7901):493-496. doi: 10.1038/s41586-022-04465-y. Epub 2022 Jan 31.